MeiraGTx Holdings PLC (NAS:MGTX)
$ 5.68 0 (0%) Market Cap: 365.26 Mil Enterprise Value: 334.43 Mil PE Ratio: 0 PB Ratio: 3.01 GF Score: 51/100

MeiraGTx Holdings PLC at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 05:15PM GMT
Release Date Price: $13.17 (-3.09%)
Alec Warren Stranahan
BofA Securities, Research Division - Associate

Hey, everyone. Good afternoon, and welcome to Day 3 of the BofA Healthcare Conference. Thanks for joining this session with MeiraGTx. My name is Alec Stranahan, I'm the analyst covering Meira here at BofA. And I'm pleased to be joined by Zandy Forbes, President and Chief Executive Officer of Meira.

And I believe Zandy is going to run through a few prepared remarks to start off, and then we'll jump into Q&A. So with that, Zandy, over to you.

Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director

Thank you, Alex (sic) [Alec]. Zandy Forbes, CEO of Meira, and I'm going to give a very brief overview of the strategy as well as the capabilities and pipeline at Meira, just a couple of minutes.

We are a company that was formed not just to address rare inherited diseases with gene therapy, although we do have a pipeline of rare inherited diseases, clinical and preclinical in collaboration with Janssen. We also focus on other diseases which are not inherited,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot